Arthur L. Holmes, B.A.
President and Chief Executive Officer
Arthur L. Holmes, B.A. serves as President and Chief Executive Officer for PharPoint. Mr. Holmes is a seasoned industry professional with nearly 20 years of experience in the pharmaceutical industry, including extensive experience in pharmaceutical consulting and contract services. Prior to PharPoint, he founded Databasics Consulting, Inc., a company specializing in systems implementation and validation for pharmaceutical and biotechnology clients. Mr. Holmes has also held management positions at Quintiles Transnational Corp. and PharmaResearch Inc, subsequently known as Kendle International. In his capacity with these companies he provided leadership in both technical and operational strategies.
Audra G. McRae, B.S.
Chief Operating Officer
Audra G. McRae, B.S. serves as Chief Operating Officer for PharPoint. Ms. McRae has worked in data services for 19 years, with 17 of those years being in the CRO industry. Ms. McRae’s data management experience ranges from providing data management support and processing for laboratory and phase I through IV clinical trials to senior management oversight of staff and processes for large international data management departments. During her tenure at PharmaResearch Inc., subsequently known as Kendle International, Ms. McRae served as Director, Clinical Data Management for the Americas. Ms. McRae is a member of the Society for Clinical Data Management and served on the Board of Directors for the society from 2003 to 2005.
Jennifer A. Elder, Ph.D.
Vice President, Biostatistics and Consulting Services
Jennifer A. Elder, Ph.D. serves as Vice President of Biostatistics and Consulting Services for PharPoint. Dr. Elder has performed statistical analyses for clinical trials for 15 years, with 11 of those years being in the CRO industry. Dr. Elder served as the lead statistician on the pivotal studies for two novel compounds in a new class of antiretroviral medications in indications for the treatment of HIV and viral hepatitis. She participated in the completion of several NDA, MAA, sNDA, and IND applications and provided strategic consulting, clinical program development planning, and statistical analysis oversight for over 75 projects. Additionally, her experience includes providing statistical support for several pharmaceutical industry-sponsored pregnancy registries and phase I through IV clinical trials. Prior to her CRO experience, Dr. Elder was an Assistant Professor of Biostatistics and a statistical consultant at the University of North Carolina at Wilmington where she maintains an adjunct affiliation. Dr. Elder has participated in the authorship of many presentations and has been an invited speaker at several industry conferences.
Amy T. Flynt, Ph.D.
Director, Biostatistics
Amy T. Flynt, Ph.D. serves as Director of Biostatistics for PharPoint. Dr. Flynt received her Ph.D. in statistics from North Carolina State University. While completing her degree, she spent three years as an intern in the clinical statistics department at a major pharmaceutical company. Prior to joining PharPoint, she worked in the pharmaceutical industry for over five years where she served as a lead statistician and provided statistical support for phase I through IV clinical trials and pharmaceutical industry-sponsored pregnancy registries. She also has served as a DMC statistician and as a statistical consultant. Her work experience has spanned various therapeutic areas, including: psychiatric disorders, cardiovascular, virology, women’s health, respiratory, pain, and oncology.
Jayme Swinson, MS.
Manager, Statistical Programming
Jayme Swinson, MS. received his M.S. in mathematics from the University of North Carolina at Wilmington. He has over 12 years experience of statistical report programming in the CRO industry. While at PharPoint, Mr. Swinson led a data standardization project culminating in the successful submission of data and analyses for an NDA. Over his career, Mr. Swinson served as a lead statistical programmer for a number of phase 1-4 clinical trials and integrated ISS/ISE analyses. He has additional experience in the analysis of data from pregnancy registries, including one registry focused on HIV drug exposure during pregnancy and birth defects. His therapeutic experience includes antivirals, pharmacoeconomics, anti-infections, respiratory, cardiovascular, epidemiology, dermatology, and sleep disorders.
Ben Bohrman, B.S.
Associate Director, Data Management
Ben Bohrman, B.S. received his BS in biology with a minor in chemistry from Georgetown College. He has worked for over 14 years in the pharmaceutical and CRO industry. During his tenure in the industry, Mr. Bohrman has managed phase 1-4 clinical trials across both EDC and paper platforms. He has broad therapeutic experience including: oncology, anti-infectives, cardiovascular, men’s/women’s health and CNS. In addition to project oversight, Mr. Bohrman provides senior management oversight for all data management services from study startup through database closure.
